A Kolkata teacher beats Stage IV ovarian cancer with advanced surgery, genetic testing, and targeted therapy—while inspiring ...

Advanced-stage high-grade serous carcinoma accounts for most ovarian cancer cases. Current issues in the management of patients with newly diagnosed advanced-stage high-grade serous ovarian cancer ...

High-grade endometrial carcinomas are a group of diverse and often diagnostically challenging tumors, which include high-grade endometrioid carcinoma (FIGO grade 3), uterine serous carcinoma ...

More than two-thirds of women with ovarian cancer have high-grade serous carcinoma. Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point ...

Researchers have made a major breakthrough in understanding the origins of one of the deadliest forms of ovarian cancer, ...

Artificial intelligence (AI) was used to predict response of high-grade extrauterine serous carcinoma (HGSC) to adjuvant platinum chemotherapy. For the first time, researchers used artificial ...

Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according ...

In previous research on high-grade serous carcinoma in the ovary, stem cells were a main culprit for cancer development after inactivation of Trp53 and Rb1. In the section of the uterine tube that ...

As per DelveInsight’s estimates, among the 7MM, the US captured the highest market of high- and low-grade serous ovarian cancer of nearly USD 1,900 million in 2024, which is expected to increase ...

Low-grade serous ovarian cancer (LGSOC) presents differently than the more common high-grade serous carcinoma. It tends to show up in younger people, grows slowly, and has higher survival rates.

CDK12 inactivation in a mouse model accelerates high-grade serous carcinoma, confirming its tumor suppressor role. Loss of CDK12 promotes aggressive tumor growth and recruits immune T cells.